REM1
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
03/16/2026
Back to search
Official data from USPTO
HEMAPRIME
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
HEMAPRIME
ST13
US500000088504710Class
1, 39, 44
Filing
88504710
Registration
6296069
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
32
Latest update
03/17/2026
Trademark type
Word
Nice classes
1, 39, 44
Filing date
07/08/2019
Registration date
03/16/2021
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
03/16/2021
Last transaction
03/17/2026
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
First use anywhere
07/10/2019
First use in commerce
07/10/2019
Drawing code
4
Owner type
03
Owner location
Northridge, CA, US
Examiner
SHEN, ELIZABETH S
Law office
L10
Current location
PUBLICATION AND ISSUE SECTION
Holders and representatives
Holders
H. C. (pessoa física)
Representatives
Joseph V. Myers III Seyfarth Shaw LLP
Technical classification
Nice Classes
Class 1Class 39Class 44
Vienna Codes
No Vienna codes available.
Goods and services
Class 1
Cells for scientific and research use; Cells for scientificlaboratory or medical research; Stem cells for research purposes; Biological tissuebloodstem cellsumbilical cords and placentas for scientific and medical research use; Biological tissuebone marrowcord bloodnormal peripheral bloodmobilized peripheral bloodfor use in scientific and medical research; Stem cells for research or scientific purposes
Class 39
Distribution servicesdelivery of human-derived donated blood products and isolated cells to hospitalsacademic institutionsbiotech and pharma companiesother related research organizations; Storage of blood; Transportdeliverypackagingstorage of human-derived biological material
Class 44
Collection and preservation of human blood
Publications
History of USPTO decisions and trademark events.
32 publications found
R.PR
REGISTERED-PRINCIPAL REGISTER
03/16/2021
SUNA
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
02/10/2021
CNPR
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
02/09/2021
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
01/05/2021
SUPC
STATEMENT OF USE PROCESSING COMPLETE
01/04/2021
EX1G
SOU EXTENSION 1 GRANTED
01/04/2021
AITU
CASE ASSIGNED TO INTENT TO USE PARALEGAL
01/04/2021
IUAF
USE AMENDMENT FILED
12/16/2020
EXT1
SOU EXTENSION 1 FILED
12/16/2020
EEXT
SOU TEAS EXTENSION RECEIVED
12/16/2020
EISU
TEAS STATEMENT OF USE RECEIVED
12/16/2020
NOAM
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
06/16/2020
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
04/21/2020
PUBO
PUBLISHED FOR OPPOSITION
04/21/2020
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
04/01/2020
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
03/19/2020
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
03/17/2020
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
03/17/2020
ALIE
ASSIGNED TO LIE
03/13/2020
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
03/06/2020
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
03/04/2020
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
03/04/2020
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
03/04/2020
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
03/04/2020
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
03/04/2020
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
10/01/2019
GNRT
NON-FINAL ACTION E-MAILED
10/01/2019
CNRT
NON-FINAL ACTION WRITTEN
10/01/2019
DOCK
ASSIGNED TO EXAMINER
09/24/2019
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
07/16/2019
NWAP
NEW APPLICATION ENTERED
07/11/2019
Continuous trademark protection
Get notified about every new filing that threatens HEMAPRIME or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.